Myomo (MYO) Revenue (QoQ) (2016 - 2025)
Myomo (MYO) Revenue (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.54% |
| Jun 30, 2025 | -1.83% |
| Mar 31, 2025 | -18.53% |
| Dec 31, 2024 | 31.07% |
| Sep 30, 2024 | 22.43% |
| Jun 30, 2024 | 100.32% |
| Mar 31, 2024 | -21.07% |
| Dec 31, 2023 | -6.36% |
| Sep 30, 2023 | -14.75% |
| Jun 30, 2023 | 72.88% |
| Mar 31, 2023 | -14.72% |
| Dec 31, 2022 | 1.85% |
| Sep 30, 2022 | 7.90% |
| Jun 30, 2022 | -4.92% |
| Mar 31, 2022 | -4.06% |
| Dec 31, 2021 | -8.04% |
| Sep 30, 2021 | 41.22% |
| Jun 30, 2021 | 32.86% |
| Mar 31, 2021 | -38.35% |
| Dec 31, 2020 | 96.71% |